Suppr超能文献

放射性防护中剂量量的使用:ICRP 出版物 147,Ann ICRP 50(1),2021 年。

The use of dose quantities in radiological protection: ICRP publication 147 Ann ICRP 50(1) 2021.

机构信息

Faculty of Health and Life Sciences, Oxford Brookes University, Oxford OX3 0BP, United Kingdom.

Public Health England, Centre for Radiation, Chemical and Environmental Hazards, Didcot, Oxon OX11 0RQ, United Kingdom.

出版信息

J Radiol Prot. 2021 Jun 1;41(2). doi: 10.1088/1361-6498/abe548.

Abstract

The International Commission on Radiological Protection has recently published a report (ICRP Publication 147;, 2021) on the use of dose quantities in radiological protection, under the same authorship as this Memorandum. Here, we present a brief summary of the main elements of the report. ICRP Publication 147 consolidates and clarifies the explanations provided in the 2007 ICRP Recommendations (Publication 103) but reaches conclusions that go beyond those presented in Publication 103. Further guidance is provided on the scientific basis for the control of radiation risks using dose quantities in occupational, public and medical applications. It is emphasised that best estimates of risk to individuals will use organ/tissue absorbed doses, appropriate relative biological effectiveness factors and dose-risk models for specific health effects. However, bearing in mind uncertainties including those associated with risk projection to low doses or low dose rates, it is concluded that in the context of radiological protection, effective dose may be considered as an approximate indicator of possible risk of stochastic health effects following low-level exposure to ionising radiation. In this respect, it should also be recognised that lifetime cancer risks vary with age at exposure, sex and population group. The ICRP report also concludes that equivalent dose is not needed as a protection quantity. Dose limits for the avoidance of tissue reactions for the skin, hands and feet, and lens of the eye will be more appropriately set in terms of absorbed dose rather than equivalent dose.

摘要

国际辐射防护委员会(ICRP)最近发布了一份关于放射性防护中剂量量使用的报告(ICRP 出版物 147;2021 年),该报告的作者与本备忘录相同。在这里,我们简要总结了报告的主要内容。ICRP 出版物 147 整合并澄清了 2007 年 ICRP 建议书(出版物 103)中的解释,但得出的结论超出了出版物 103 中的结论。进一步提供了关于使用职业、公众和医疗应用中的剂量量控制辐射风险的科学依据的指导。强调了使用器官/组织吸收剂量、适当的相对生物有效性因素和特定健康影响的剂量-风险模型对个体风险进行最佳估计的重要性。然而,考虑到不确定性,包括与低剂量或低剂量率的风险预测相关的不确定性,得出的结论是,在放射防护方面,有效剂量可被视为低水平电离辐射暴露后可能发生随机健康影响的风险的近似指标。在这方面,还应该认识到,终生癌症风险随暴露年龄、性别和人群群体而变化。ICRP 报告还得出结论,等效剂量不需要作为防护量。为避免皮肤、手和脚以及眼睛晶状体的组织反应而设定的剂量限值将更适当地根据吸收剂量而不是等效剂量来设定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验